Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Assets Average (2016 - 2025)

Historic Assets Average for Trinity Biotech (TRIB) over the last 17 years, with Q2 2025 value amounting to $101.5 million.

  • Trinity Biotech's Assets Average rose 988.9% to $101.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $101.5 million, marking a year-over-year increase of 988.9%. This contributed to the annual value of $81.4 million for FY2024, which is 738.16% up from last year.
  • Latest data reveals that Trinity Biotech reported Assets Average of $101.5 million as of Q2 2025, which was up 988.9% from $100.4 million recorded in Q4 2024.
  • Trinity Biotech's 5-year Assets Average high stood at $133.2 million for Q1 2021, and its period low was $61.5 million during Q4 2023.
  • Its 5-year average for Assets Average is $99.5 million, with a median of $100.4 million in 2024.
  • As far as peak fluctuations go, Trinity Biotech's Assets Average tumbled by 3524.6% in 2023, and later surged by 6315.76% in 2024.
  • Trinity Biotech's Assets Average (Quarter) stood at $120.8 million in 2021, then dropped by 21.38% to $95.0 million in 2022, then tumbled by 35.25% to $61.5 million in 2023, then surged by 63.16% to $100.4 million in 2024, then rose by 1.09% to $101.5 million in 2025.
  • Its last three reported values are $101.5 million in Q2 2025, $100.4 million for Q4 2024, and $95.9 million during Q3 2024.